Vimarsana
Biggest News Aggregation in the World

Page 3 - Targeted Agents News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Targeted Agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Targeted Agents Today - Breaking & Trending Today

Oxford BioTherapeutics to Present Initial Positive Data from Phase I Trial at ASCO 2022 - Vimarsana News

Oxford BioTherapeutics to Present Initial Positive Data from Phase I Trial at ASCO 2022

Initial data from Phase 1 dose escalation part of the trial, assessing OBT076 in adult patients with advanced solid tumors, indicated that OBT076 was generally...

Jacobio will Present Phase I Clinical Data of KRAS G12C Inhibitor JAB-21822 at the 2022 ASCO Annual Meeting - Vimarsana News

Jacobio will Present Phase I Clinical Data of KRAS G12C Inhibitor JAB-21822 at the 2022 ASCO Annual Meeting

/PRNewswire/ -- Jacobio Pharma (1167.HK) is pleased to announce that the phase I clinical data of KRAS G12C inhibitor JAB-21822 will be presented in the form...

Dermatitis Market Player Collaborations Help Drive Growth Rate At 8% - Vimarsana News

Dermatitis Market Player Collaborations Help Drive Growth Rate At 8%

The Business Research Company’s Dermatitis Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

Jazz to Present New Data at ASCO and EHA 2021 Meetings Showcasing Clinical Advances Across Hematology and Oncology Portfolio - Vimarsana News

Jazz to Present New Data at ASCO and EHA 2021 Meetings Showcasing Clinical Advances Across Hematology and Oncology Portfolio

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its investigator sponsors will present four new abstracts at the virtual...